Peter Boström - UTU Research Portal

Peter Boström

- Associate Professor,
Surgery (Department of Clinical Medicine)

peter.bostrom@utu.fi

: https://orcid.org/0000-0003-3647-0015

11 of 12

Reply from authors re: Robert S. Svatek. Long-term outcomes of the FinnBladder-4 study. Eur Urol 2015;68:618-9: which type of maintenance matters? (2015)
- European Urology
Järvinen R, Kaasinen E, Marttila T, Rintala E, Boström P
Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer (2015)
- PLoS ONE
Boström MM, Irjala H, Mirtti T, Taimen P, Kauko T, Ålgars A, Jalkanen S, Boström PJ
Bulbourethral gland adenocarcinoma in a 25-year-old man without comorbidities – Radical resection of proximal urethrae with Mitrofanoff-type appendicovesicostomy (2014)
- Scandinavian Journal of Urology and Nephrology
Syvänen KT, Taimen P, Salminen A, Kuusisto K, Boström PJ
European Association of Urology (@Uroweb) – Recommendations on the Appropriate Use of Social Media (2014)
- European Urology
Morgan Rouprêt, Todd M. Morgan, Peter J. Bostrom, Matthew R. Cooperberg, Alexander Kutikov, Kate D. Linton, Joan Palou, Luis Martínez-Piñeiro, Henk van der Poel, Carl Wijburg, Andrew Winterbottom, Henry H. Woo, Manfred P. Wirth, James W.F. Catto
FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer (2014)
- Virchows Archiv
Yann Neuzillet, Bas W. G. van Rhijn, Nadia L. Prigoda, Bharati Bapat, Liyang Liu, Peter J. Bostrom, Neil E. Fleshner, Brenda L. Gallie, Alexandre R. Zlotta, Michael A. S. Jewett, Theo H. van der Kwast
Le Fibroblast Growth Factor Receptor 3 (FGFR3), cible thérapeutique pour le traitement personnalisé du cancer de la vessie : validation anatomo-pathologique du concept (2014)
- Progrès en Urologie
Neuzillet Y, Mertens L, Shariat S, Bostrom P, Mirtti T, Sagalowsky A, Ashfaq R, Broeks A, Van der Heijden M, Peters D, Curial C, De Jong J, Horenblas S, Hurst C, Tomlinson D, Knowles M, Bapat B, Jewett M, Zlotta A, Sanders J, Lotan Y, Van der Kwast T, Van Rhijn B
Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer (2014)
- European Medical Journal Urology
Syvänen K, Järveläinen H, Taimen P, Laato M, Boström PJ
Patient-derived tissue culture and xenograft models for studying prostate tumor responses to therapy (2014)
- European Journal of Cancer
Yu L, Kahkonen TE, Taimen P, Bostrom P, Tuomela J, Harkonen P
Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy (2014)
- Urologic Oncology: Seminars and Original Investigations
Seikkula H, Syvänen K, Kurki S, Mirtti T, Taimen P, Laato M, Boström P
Kives- ja lisäkiveskasvaimet (2013) Urologia Laato M, Boström P
Kivessyövän hoito ja seuranta räätälöidään riskiluokituksen mukaan (2013)
- Lääkärilehti
Ylönen O, Jyrkkiö S, Varis J, Perheentupa A, Ruohola J, Minn H, Boström P
Miehen sukupuolielinten tulehdukset (2013) Urologia Laato M, Boström P, Leskinen MJ, Juusela H
Munuaissyövän yleisyys ja vaaratekijät (2013) Syöpätaudit Bono P, Joensuu H, Rintala E, Boström P
Patients with Lynch Syndrome Mismatch Repair Gene Mutations Are at Higher Risk for Not Only Upper Tract Urothelial Cancer but Also Bladder Cancer (2013)
- European Urology
Skeldon SC, Semotiuk K, Aronson M, Holter S, Gallinger S, Pollett A, Kuk C, van Rhijn B, Bostrom P, Cohen Z, Fleshner NE, Jewett MA, Hanna S, Shariat SF, Van der Kwast TH, Evans A, Catto J, Bapat B, Zlotta AR
Peniskasvaimet (2013) Urologia Laato M, Boström P
Seminal vesicles and urinary bladder as sites of aromatization of androgens in men, evidenced by a CYP19A1-driven luciferase reporter mouse and human tissue specimens (2013)
- FASEB Journal
Strauss L, Rantakari P, Sjogren K, Salminen A, Lauren E, Kallio J, Damdimopoulou P, Bostrom M, Bostrom PJ, Pakarinen P, Zhang FP, Kujala P, Ohlsson C, Makela S, Poutanen M
Upper urinary tract and urethral recurrences following radical cystectomy – review of risk factors and outcomes between centres with different follow-up protocols (2013)
- World Journal of Urology
Perlis N, Turker P, Bostrom PJ, Kuk C, Mirtti T, Kulkarni G, Fleshner NE, Jewett MAS, Finelli A, Zlotta AR
Hypoxia is independently associated with poor outcome in urothelial bladder cancer patients treated with radical cystectomy (2012)
- European Urology Supplements
Bostrom PJ, Thoms J, Van Rhijn BWG, Ahmed O, Stakhovskyi O, Margel D, Evans A, Mirtti T, Sykes J, Pintilie M, Laato M, Milosevic M, Zlotta AR, Bristow RG
HYPOXIA IS INDEPENDENTLY ASSOCIATED WITH POOR OUTCOME IN UROTHELIAL BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY (2012)
- Journal of Urology
Bostrom PJ, Thoms J, van Rhijn BWG, Ahmed O, Stakhovskyi O, Margel D, Evans A, Mirtti T, Sykes J, Pintillie M, Laato M, Milosevic M, Zlotta AR, Bristow RG
Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome (2012)
- BJU International
Turker P, Bostrom PJ, Wroclawski ML, van Rhijn B, Kortekangas H, Kuk C, Mirtti T, Fleshner NE, Jewett MA, Finelli A, Kwast TV, Evans A, Sweet J, Laato M, Zlotta AR